Protia Inc. (KOSDAQ:303360)
South Korea · Delayed Price · Currency is KRW 4,635.00
-40.00 (-0.86%)
At close: Apr 9, 2026
Protia Revenue
In the year 2025, Protia had annual revenue of 15.12B KRW with 43.80% growth. Protia had revenue of 4.55B in the quarter ending December 31, 2025, with 54.23% growth.
Revenue
15.12B
Revenue Growth
+43.80%
P/S Ratio
3.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
59.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.12B | 4.61B | 43.80% |
| Dec 31, 2024 | 10.51B | 2.29B | 27.79% |
| Dec 31, 2023 | 8.23B | 583.85M | 7.64% |
| Dec 31, 2022 | 7.64B | 4.09B | 115.34% |
| Dec 31, 2016 | 3.55B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Cross Medical Science | 108.41B |
| Seoulin Bioscience | 77.09B |
| Dx & Vx | 29.36B |
| Cytogen | 26.05B |
| HLB Panagene | 15.05B |
| 3billion | 11.71B |
| GENINUS | 10.48B |
| Median Diagnostics | 7.86B |